SCHEMBL7426538

SCHEMBL7426538

CC1Cc2cc3c(ccn3C)cc2N1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 8/20 0.44
CREBBP Q92793 7/20 0.44
AR P10275 2/20 0.41
PRKCI P41743 1/20 0.39
CYP2A6 P11509 2/20 0.36
PIK3CB P42338 1/20 0.36
GAA P10253 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 2/20 0.33
PGR P06401 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TSHR P16473 1/20 0.33
EP300 Q09472 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9043416 0.78 BRD4 (0.36) BRD4CREBBPPRKCICYP2A6GAA
SCHEMBL18683804 0.74 PRKCI (0.60) BRD4CREBBPPRKCICYP2A6PIK3CB
SCHEMBL7415949 0.72 AR (0.40) ARPRKCICYP2A6PIK3CBMAPT
SCHEMBL12965849 0.72 AR (0.45) BRD4CREBBPARGAALMNA
SCHEMBL12965982 0.70 AR (0.44) BRD4CREBBPARGAALMNA
SCHEMBL7420662 0.70 MAPT (0.44) PRKCICYP2A6PIK3CBGAALMNA
SCHEMBL13881963 0.69 LMNA (0.44) BRD4CREBBPARGAALMNA
SCHEMBL28379496 0.69 CA9 (0.44) BRD4CREBBPCYP2A6MAPTALDH1A1
SCHEMBL18873365 0.68 PRKCI (0.46) PRKCICYP2A6PIK3CBMAPTSMN1; SMN2
SCHEMBL26569894 0.68 PRKCI (0.58) PRKCICYP2A6PIK3CBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0656003-A1 CONDENSED INDOLE DERIVATIVES AS 5HT2C AND 5HT2B ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-07 EP disclosed
WO-1994004533-A1 CONDENSED INDOLE DERIVATIVES AS 5HT2C AND 5HT2B ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-03-03 WO disclosed